Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Test for Detecting Infection in Prosthetic Joints

By HospiMedica staff writers
Posted on 28 Aug 2007
A new diagnostic test to detect infection of prosthetic joints by sampling bacteria that adhere to the prosthetic surface, could potentially lead to better treatment options and patient outcomes.

Researchers at the Mayo Clinic (Rochester, MN, USA) tested 331 patients with prosthetic hip or knee joints who were having their prosthetic joints removed for infection or other causes. More...
The new test involves removing the prosthetic joint, placing it in a special container, and sending it to the laboratory. In the laboratory, a solution is added to the container, which is then subjected to a combination of vortexing (shaking) and sonication (exposure to ultrasound), which has been shown to remove biofilm bacteria. The bacteria in the solution are then quantitatively cultured. The new diagnostic test detected more of the infected cases (78.5%) than did the conventional approach (60.8%), which samples tissue around the prosthetic joint at the time of surgery. The study was published in the August 16, 2007, issue of the New England Journal of Medicine (NEJM).

"The problem with the conventional method is that you need multiple tissue specimens, because the sensitivity of a single specimen is not good--in other words, the infection might be missed with just one sample,” said lead author Prof. Robin Patel, M.D. "Another issue is that bacteria normally found on the skin can be picked up on the tissue specimen as it is extracted and passes through the skin, yielding a false-positive result. These same bacteria may actually cause the infection, so doctors can't always tell just by the type of bacteria detected whether the patient has an infection or not. If multiple specimens are positive for the bacteria, then this indicates that the bacteria are causing the infection.”


Related Links:
Mayo Clinic

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.